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Received February 17, 2014; accepted June 12, 2014AbstractBackground: Postoperative nausea and vomiting as well as postoperative pain are two major concerns when patients undergo surgery and receive
anesthetics. Various models and predictive methods have been developed to investigate the risk factors of postoperative nausea and vomiting, and
different types of preventive managements have subsequently been developed. However, there continues to be a wide variation in the previously
reported incidence rates of postoperative nausea and vomiting. This may have occurred because patients were assessed at different time points,
coupled with the overall limitation of the statistical methods used. However, using survival analysis with Cox regression, and thus factoring in
these time effects, may solve this statistical limitation and reveal risk factors related to the occurrence of postoperative nausea and vomiting in
the following period.
Methods: In this retrospective, observational, uni-institutional study, we analyzed the results of 229 patients who received patient-controlled
epidural analgesia following surgery from June 2007 to December 2007. We investigated the risk factors for the occurrence of postoperative
nausea and vomiting, and also assessed the effect of evaluating patients at different time points using the Cox proportional hazards model.
Furthermore, the results of this inquiry were compared with those results using logistic regression.
Results: The overall incidence of postoperative nausea and vomiting in our study was 35.4%. Using logistic regression, we found that only sex,
but not the total doses and the average dose of opioids, had significant effects on the occurrence of postoperative nausea and vomiting at some
time points. Cox regression showed that, when patients consumed a higher average dose of opioids, this correlated with a higher incidence of
postoperative nausea and vomiting with a hazard ratio of 1.286.
Conclusion: Survival analysis using Cox regression showed that the average consumption of opioids played an important role in postoperative
nausea and vomiting, a result not found by logistic regression. Therefore, the incidence of postoperative nausea and vomiting in patients cannot
be reliably determined on the basis of a single visit at one point in time.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Postoperative nausea and vomiting and postoperative pain
are two major concerns in patients receiving surgeries and
anesthetics.1 Frequently, postoperative nausea and vomiting
occurs in patients receiving general, regional, or local anes-
thesia and causes significant suffering.2e4 Sometimes, patients
prefer to endure postoperative pain rather than receive opioids
that may result in postoperative nausea and vomiting,5 andociation. All rights reserved.
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therapies.6
Previous studies attempted to investigate the incidence and
risk factors of postoperative nausea and vomiting using
different predictive models.7e10 However, the incidences of
postoperative nausea and vomiting explored in previous
studies ranged from 10% to 30% in general anesthesia2,11e14
and from 3.2% to 34% in patients receiving patient-
controlled epidural analgesia.15e21 This disparity may be
attributable to the different time points used when the patients
were visited. Postoperative nausea and vomiting could occur
several minutes, hours, or even days after anesthesia. If the
investigation of postoperative nausea and vomiting is limited
to a specified time point, the analysis will be confounded.
In this study, we analyzed the information obtained by
repeatedly visiting the patients to explore the risk factors and
incidence of postoperative nausea and vomiting, and assessed
the effects of time points, which have rarely been discussed in
the literature. When considering the effects of time, survival
analysis was applied to analyze the occurrence of postoperative
nausea and vomiting. We compared the results obtained by lo-
gistic regression to those determined by survival analysis to
elucidate the differences between the two statistical methods.
This research may contribute to a clearer understanding of the
incidence of postoperative nausea and vomiting.
2. Methods
In this retrospective, observational, uni-institutional (a
medical center in central Taiwan) study, we analyzed the re-
sults of 229 patients receiving postsurgical patient-controlled
epidural analgesia from June 2007 to December 2007.
Ethical approval was obtained from the Institutional Review
Board of Taichung Veterans General Hospital. The data were
reviewed for patients receiving general anesthesia for the
following surgeries: (1) upper abdomen surgery; (2) lower
abdomen surgery; and (3) chest surgery. The composition
prescription in patient-controlled epidural analgesia consists of
bupivacaine (0.1%) and fentanyl (1.5 mg/mL) in normal saline
(500 mL). We collected data including age, sex, body mass
index, types of surgery, the setting of patient-controlled anal-
gesia pumps, total dosage (mL) and average dosage (mL/hour)
of patient-controlled epidural analgesia, and the time point of
postoperative nausea and vomiting occurrence.
In our institution, patients were visited five times over a 3-
day period of patient-controlled epidural analgesia use, and the
five time points were as follows: (1) the first visit on operation
day (OPD-1); (2) the second visit on operation day (OPD-2);
(3) the third visit on the 1st postoperative day (POD-1-1); (4)
the fourth visit on the 1st postoperative day (POD-1-2); and (5)
the fifth and final visit on the 2nd postoperative day (POD-2). If
the patient had used patient-controlled epidural analgesia on
the first visit, the zero time point was backtracked by calcu-
lating the average dosage on the first visit.
When patients were receiving patient-controlled epidural
analgesia, we followed up the patients and adjusted the depth
of the epidural catheter or the dosage of medications accordingto the patients' pain intensity at rest and in motion after sur-
geries. Our goal was to keep the patients' pain intensity below
3 at rest and below 5 in motion by using the numeric rating
scale (where 0 ¼ no pain and 10 ¼ most intense pain imag-
inable). When analgesia in the required dermatome failed or
was found to be inadequate, the type of pain management
would be changed to other regimens such as intravenous
patient-controlled analgesia. Consequently, these patients were
not included in this study.
IBM SPSS Statistics 20 (IBM SPSS Inc. Chicago, IL, USA)
was used to analyze these data. The Cox proportional hazards
model (Cox model) was used to determine the correlations
between variables and survival time to calculate the odds ratio
of the risk factors. When patients suffered from postoperative
nausea and vomiting in the following periods, it was defined as
the occurrence of an event. Survival time was outlined as the
time duration until the occurrence of postoperative nausea and
vomiting. If an event did not occur in the following period,
then the patient was assumed to be censored. We also applied
logistic regression to analyze the correlations between vari-
ables and the incidences of postoperative nausea and vomiting
at specific time points, and compared the results with those
obtained using the Cox model. Both in the Cox model and
logistic regression, the forward likelihood ratio was used to
identify significant variables. A p value <0.05 was considered
significant.
3. Results
A total of 229 patients received patient-controlled epidural
analgesia for postoperative pain control between June 2007
and December 2007. The demographic data of the patients are
shown in Table 1. The settings of patient-controlled analgesia
pumps were as follows: bolus dosage, 4.38 ± 0.94 mL;
continuous infusion dosage, 4.25 ± 1.18 mL; lockout time,
17.9 ± 4.6 minutes; and 4-hour upper limit dosage,
46.8 ± 11.25 mL. In patients with and without postoperative
nausea and vomiting, the average total dosage of patient-
controlled analgesia was 106.5 ± 91.73 mL versus
279.2 ± 98.85 mL and the duration of patient-controlled
analgesia use was 16 ± 14.4 hours versus 46.7 ± 6 hours,
respectively. The overall incidence of postoperative nausea
and vomiting was 35.4% (Table 1), and ranged from 5.5% to
17.6% at five different time points (Table 2). The highest
incidence of postoperative nausea and vomiting was noted at
the third visit on postoperative Day 1 (POD-1-1); the lowest
was found at OPD-1 (Table 2).
Before logistic regression was applied to explore the risk
factors for incidence of postoperative nausea and vomiting in
patients with patient-controlled epidural analgesia, univariate
analysis of candidate variables was performed. These results,
as provided in Table 3, revealed that age, sex, height, and
surgical sites may play significant roles in predicting the
occurrence of postoperative nausea and vomiting in POD-1-1,
POD-1-2, or POD-2.
At three time points (POD-1-1, POD-1-2, and POD-2), sex
was found to have a significant influence on the occurrence of
Table 1
Demographic data.
Characteristic Sex (M/F) 143/86
Age (y) 58.71 (16.88)
Height (cm) 161.71 (8.14)
Weight (kg) 60.3 (10.53)
BMI 23.02 (3.36)
Event (1/0)a 81/148
















Other lower abdomen surgery 8
Numbers found in parentheses represent standard deviations.
BMI ¼ body mass index; F ¼ female; M ¼ male.
a Event: 1 ¼ the occurrence of postoperative nausea and vomiting in the
following periods; 0 ¼ no occurrence of postoperative nausea and vomiting in
the following periods.
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appeared to be more likely (3.013, 2.790, and 3.015 times) to
suffer from postoperative nausea and vomiting than male pa-
tients at these three time points. In addition, the surgical sites
of the patients were noted to have an effect on the occurrence
of postoperative nausea and vomiting at POD-1-2 and POD-2
(Table 4). Patients undergoing surgeries in the upper abdomen
may have a higher risk of developing postoperative nausea and
vomiting than those receiving surgeries in the chest, and the
odds ratios were 4.490 and 4.834, respectively, at the above
mentioned time points.
Cox regression was used to analyze the risk factors of
postoperative nausea and vomiting incidence in patients with
patient-controlled epidural analgesia based on the time to
occurrence of events (Table 5). The result in step 1 shows that
the greater the total dosage of opioids, the lower the risk of
postoperative nausea and vomiting with a hazard ratio of
0.988. In the final steps, a higher average dose of opioids
consumed was correlated with a higher incidence of post-
operative nausea and vomiting, with a hazard ratio of 1.286.
Furthermore, female patients were more likely (a hazard ratio
of 2.501) to suffer from postoperative nausea and vomiting
than male patients, and patients with a higher body mass index
were at a higher risk of suffering from postoperative nausea
and vomiting, with a hazard ratio of 1.103.
4. Discussion
In this study, the overall incidence of postoperative nausea
and vomiting was 35.4%, which was higher than the resultsfound by previous studies.2,11e14 The incidence of post-
operative nausea and vomiting varied with time and ranged
from 5.5% to 17.6% at five different time points (Table 2). We
explored the total occurrence of events through five time
points, which would make the investigation more compre-
hensive than by only following up the patients at a single time
point, and thus a higher incidence of postoperative nausea and
vomiting was obtained. The disparity between the incidences
of postoperative nausea and vomiting at five time points may
reflect the inconsistent results from previous investigations
owing to the different visiting time points used in each
study.2,11e14
Results of analyses by logistic regression showed that fe-
male patients were more likely (approximately 3 times more)
to suffer from postoperative nausea and vomiting than male
patients at three time points (Table 4). The total doses and the
average dose of opioids were not found to have a significant
effect on the occurrence of postoperative nausea and vomiting.
The results support the notion that the risk factors of post-
operative nausea and vomiting identified by logistic regression
could be affected by different time points and may therefore
result in conflicting findings.7e10,22
Although other statistical techniques such as generalized
estimating equation or mixed model could be applied to
analyze the data collected repeatedly, our focus was on the
occurrence of postoperative nausea and vomiting and the
duration until the occurrence of the first event. Therefore, we
applied the Cox proportional hazards model to analyze the
factors with respect to time to occurrence of postoperative
nausea and vomiting. The results showed that in addition to
sex, which was found by logistic regression, body mass index
and the average and total dose of opioids were also found to
play significant roles in the occurrence of postoperative nausea
and vomiting (Table 5).
Several studies have shown that consumption of post-
operative opioids was one of the risk factors related to the
occurrence of postoperative nausea and vomiting23,24; how-
ever, other studies did not support this conclusion.7,25,26 Very
few studies have investigated the relationship between the
dosage of opioids and the occurrence of postoperative nausea
and vomiting, factoring in the time effects.27 The inconsistent
findings may be attributable to the limitations of logistic
regression and the use of different visiting time points. The
results showed that patients requiring larger doses of opioids
were less likely to suffer from postoperative nausea and
vomiting (Table 5), which may be attributable to the time
factor. Therefore, the average dose of opioids instead of the
total dosage of opioids consumed by patients could account
for this phenomenon.
The above results indicate that investigations of risk factors
and the incidence of postoperative nausea and vomiting may
be influenced by the visiting time points and the use of sta-
tistical methods. Analysis of the data to predict postoperative
nausea and vomiting by logistic regression focuses on the
finding of the risk factors at a definite time point. In this study,
we found that the risk factors and incidence of postoperative
nausea and vomiting investigated by logistic regression
Table 2







OPD-1 ¼ the first visit on operation day; OPD-2 ¼ the second visit on
operation day; POD-1-1 ¼ the third visit on the 1st postoperative day; POD-1-
2 ¼ the fourth visit on the 1st postoperative day; POD-2 ¼ the fifth and final
visit on the 2nd postoperative day.
Table 4
Risk factors of postoperative nausea and vomiting in patients with patient-
controlled epidural analgesia analyzed by logistic regression.
Time point Sexa Surgical site
Chest Upper abdomen
POD-1-1 3.013 (1.451e6.260)* 1
POD-1-2 2.790 (1.064e7.315)* 1 4.490 (1.394e14.456)*
POD-2 3.015 (1.143e7.952)* 1 4.834 (1.518e15.394)*
Only variables exhibiting significant effects in the occurrence of postoperative
nausea and vomiting are exhibited in the table.
The numbers represent odds ratio values; numbers found within parentheses
represent 95% confidence intervals.
*p < 0.05.
POD-1-1 ¼ the third visit on the 1st postoperative day; POD-1-2 ¼ the fourth
visit on the 1st postoperative day; POD-2 ¼ the fifth and final visit on the 2nd
postoperative day.
a The reference group comprises the male patients.
Table 5
Risk factors of postoperative nausea and vomiting in patients with patient-
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models established by logistic regression, we may suggest to a
patient that there is no need for prophylaxis for postoperative
nausea and vomiting at a specific time point such as the 1st
postoperative day. However, the patient may experience
postoperative nausea and vomiting on the 2nd postoperative
day because the condition of the predictive models changed.
If we hope to survey the risk factors of postoperative nausea
and vomiting during the entire course of follow up, and not
only at any one time point, application of the Cox regression
model may be more optimal than the conventional logistic
regression. By using this approach, we may achieve a more
comprehensive prophylaxis of the postoperative nausea and
vomiting. Cox regression has seldom been used to investigate
the occurrence of postoperative nausea and vomiting, but it has
presented a different viewpoint that did not conflict with the
results found in previous studies analyzed with logistic
regression.23,28
The average consumption of opioids was proven to be an
important factor in the occurrence of postoperative nausea and
vomiting during the following course of treatment, and this
finding may further support the use of multimodal pain con-
trol. Use of gabapentin or nonsteroidal anti-inflammatory
drugs would reduce the consumption of opioids and may
lead to a decreased occurrence or severity of postoperative
nausea and vomiting.29,30 There is reason to believe that these
strategies would offer better postoperative care.
Standl et al3 and Pusch et al4 discovered that patients
receiving general anesthesia were more likely to suffer fromTable 3
Univariate analysis of variables predicting the occurrence of postoperative
nausea and vomiting by logistic regression.
Time point POD-1-1 POD-1-2 POD-2
Age (y) 0.243 0.005 0.061
Sex (M/F) 0.004 0.02 0.014
Height (cm) 0.035 0.035 0.013
Weight (kg) 0.73 0.74 0.68
BMI 0.30 0.057 0.204
Surgical site 0.77 0.003 0.022
Dose (mL) 0.177 0.862 0.989
Average dose (mL/h) 0.852 0.98 0.431
The data represent p values from either Student t test or Chi-square test.
BMI ¼ body mass index; F ¼ female; M ¼ male; POD-1-1¼ the third visit on
the 1st postoperative day; POD-1-2 ¼ the fourth visit on the 1st postoperative
day; POD-2 ¼ the fifth and final visit on the 2nd postoperative day.postoperative nausea and vomiting than patients receiving
regional anesthesia. Wilhelm et al14 concluded that the sites
and types of surgeries may influence the incidence of post-
operative nausea and vomiting. In order to decrease the effect
of confounding factors, we surveyed the patients receiving
general anesthesia for just three types of surgery: upper
abdomen, lower abdomen, and chest surgeries. Patients with
different surgeries may suffer from various intensities of
postoperative pain, but they would optimize their post-
operative analgesia by using epidural patient-controlled anal-
gesia.31,32 Therefore, the occurrence of postoperative nausea
and vomiting may be analyzed more discriminatively and
predictably by investigating the individualized doses of anal-
gesia regimen consumed than by exploring the effects of
different surgeries. Most studies23,24 that sought to predict the
occurrence of postoperative nausea and vomiting comprised
only the types of surgeries involved. They frequently lacked
information about the detailed surgical methods that would
make the analysis results relevant not only for a specific sur-
gery, but also more broadly applicable to more generalized
procedures.controlled epidural analgesia analyzed by Cox regression.
Variables Hazard ratio* 95% CI
Step 1 Dose (mL) 0.988 0.985e0.990
Step 2 Average dose (mL/h) 1.293 1.214e1.377
Dose (mL) 0.983 0.980e0.986
Step 3 Sexa 2.479 1.495e4.109
Average dose (mL/h) 1.293 1.213e1.378
Dose (mL) 0.982 0.978e0.985
Step 4 Sexa 2.501 1.507e4.151
BMI 1.103 1.022e1.189
Average dose (mL/h) 1.286 1.207e1.370
Dose (mL) 0.981 0.978e0.985
Only variables exhibiting significant effects in the occurrence of postoperative
nausea and vomiting are exhibited in the table.
*p < 0.05.
BMI ¼ body mass index; CI ¼ confidence interval.
a The reference group comprises the male patients.
593S.-Y. Lee et al. / Journal of the Chinese Medical Association 77 (2014) 589e593The present study was a retrospective investigation, and the
patient-controlled epidural analgesia data were collected from
the patients' medical records. Previous studies revealed various
risk factors for postoperative nausea and vomiting, including a
history of smoking, motion sickness, postoperative nausea,
and vomiting7e10 which could not be collected by reviewing
the patient charts in the present study. Another limitation in
the present retrospective study was that we did not include in
the analyses the opioids used in anesthesia and the rescue or
extra opioids administered in the ward.
In conclusion, a wide variation of the risk factors and the
incidence of postoperative nausea and vomiting may exist
because patients were assessed at different time points,
coupled with the overall limitation of statistical methods.
Visiting patients at different time points and using Cox
regression that could factor in the time effects would allow
researchers to explore the investigation of postoperative
nausea and vomiting more comprehensively. Multimodal pain
management and prophylaxis treatment of postoperative
nausea and vomiting could offer better postoperative care.
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